Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00031
http://purl.obolibrary.org/obo/dinto_DB00031
|
|---|---|
| Preferred Name | tenecteplase |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | tenecteplase
|
|---|---|
| label | tenecteplase
|
| DBSynonym |
t-plasminogen activator
tissue-type plasminogen activator precursor
t- pa
tpa
|
| ATCCode | B01AD11
|
| Definition | Tissue plasminogen activator (tPA). Tenecteplase is a 527 amino acid glycoprotein developed by introducing the following modifications to the complementary DNA (cDNA) for natural human tPA: a substitution of threonine 103 with asparagine, and a substitution of asparagine 117 with glutamine, both within the kringle 1 domain, and a tetra-alanine substitution at amino acids 296-299 in the protease domain.
|
| has pharmacological target | |
| type | |
| AHFScode | 20:12.20
|
| xref |
Drugs.com:http://www.drugs.com/mtm/tenecteplase.html
PharmGKB:PA164776757
National Drug Code Directory:50242-038-61
GenBank:L00153
Wikipedia:http://en.wikipedia.org/wiki/Tenecteplase
RxList:http://www.rxlist.com/cgi/generic2/tenecteplase.htm
Drugs Product Database (DPD):2244826
UniProtKB:P00750
See more
See less
|
| CASRN | 191588-94-0
|
| prefixIRI | obo2:dinto_DB00031
|
| related with |
See more
See less
|
| may interact with | |
| DBBrand | tnkase (genentech inc)
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |